These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32794634)

  • 1. The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population-based retrospective matched cohort analysis.
    Barbera L; Sutradhar R; Seow H; Mittmann N; Howell D; Earle CC; Li Q; Thiruchelvam D
    Cancer Med; 2020 Oct; 9(19):7107-7115. PubMed ID: 32794634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Standardized Edmonton Symptom Assessment System Use on Emergency Department Visits and Hospitalization: Results of a Population-Based Retrospective Matched Cohort Analysis.
    Barbera L; Sutradhar R; Seow H; Earle CC; Howell D; Mittmann N; Li Q; Thiruchelvam D
    JCO Oncol Pract; 2020 Sep; 16(9):e958-e965. PubMed ID: 32463762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of routine Edmonton symptom assessment system use on receiving palliative care services: results of a population-based retrospective-matched cohort analysis.
    Barbera L; Sutradhar R; Earle CC; Howell D; Mittman N; Li Q; Thiruchelvam D; Seow H
    BMJ Support Palliat Care; 2023 Oct; 13(e1):e144-e149. PubMed ID: 32943469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of symptom screening on survival among patients with cancer across varying levels of pre-diagnosis psychiatric care.
    Sutradhar R; Li Q; Kurdyak P; Barbera L
    Cancer Med; 2022 Feb; 11(3):838-846. PubMed ID: 34931479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are population-based patient-reported outcomes associated with overall survival in patients with advanced pancreatic cancer?
    Dai WF; Beca J; Guo H; Isaranawatchai W; Schwartz D; Naipaul R; Arias J; Qiao Y; Gavura S; Redmond-Misner R; Ismail Z; Barbera L; Chan K
    Cancer Med; 2020 Jan; 9(1):215-224. PubMed ID: 31736256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of automated screening with Edmonton Symptom Assessment System (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients.
    Diplock BD; McGarragle KMC; Mueller WA; Haddad S; Ehrlich R; Yoon DA; Cao X; Al-Allaq Y; Karanicolas P; Fitch MI; Myers J; Mitchell AJ; Ellis JWM
    Support Care Cancer; 2019 Jan; 27(1):209-218. PubMed ID: 29931490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Reported Symptoms Improve Performance of Risk Prediction Models for Emergency Department Visits Among Patients With Cancer: A Population-Wide Study in Ontario Using Administrative Data.
    Sutradhar R; Rostami M; Barbera L
    J Pain Symptom Manage; 2019 Nov; 58(5):745-755. PubMed ID: 31319103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of a provincial symptom assessment program in reaching adolescents and young adults with cancer: A population-based cohort study.
    Gupta S; Sutradhar R; Li Q; Coburn N
    Cancer Med; 2021 Dec; 10(24):9030-9039. PubMed ID: 34738747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncology Nurses' Attitudes Toward the Edmonton Symptom Assessment System: Results From a Large Cancer Care Ontario Study.
    Green E; Yuen D; Chasen M; Amernic H; Shabestari O; Brundage M; Krzyzanowska MK; Klinger C; Ismail Z; Pereira J
    Oncol Nurs Forum; 2017 Jan; 44(1):116-125. PubMed ID: 27991609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Care Professionals' Attitudes Toward Systematic Standardized Symptom Assessment and the Edmonton Symptom Assessment System After Large-Scale Population-Based Implementation in Ontario, Canada.
    Pereira JL; Chasen MR; Molloy S; Amernic H; Brundage MD; Green E; Kurkjian S; Krzyzanowska MK; Mahase W; Shabestari O; Tabing R; Klinger CA
    J Pain Symptom Manage; 2016 Apr; 51(4):662-672.e8. PubMed ID: 26743641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Patient-Reported Outcomes With Subsequent Nonfatal Self-injury After a New Cancer Diagnosis.
    Hallet J; Sutradhar R; Isenberg-Grzeda E; Noel CW; Mahar AL; Vigod SN; Bolton J; Deleemans J; Chan WC; Coburn NG; Eskander A;
    JAMA Oncol; 2022 May; 8(5):e220203. PubMed ID: 35357419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care: Perspectives of Patients and Providers on ESAS-r:Renal.
    Evans JM; Glazer A; Lum R; Heale E; MacKinnon M; Blake PG; Walsh M
    Clin J Am Soc Nephrol; 2020 Sep; 15(9):1299-1309. PubMed ID: 32843371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multistate Models for Examining the Progression of Intermittently Measured Patient-Reported Symptoms Among Patients With Cancer: The Importance of Accounting for Interval Censoring.
    Sutradhar R; Barbera L
    J Pain Symptom Manage; 2021 Jan; 61(1):54-62. PubMed ID: 32688014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.
    Tjong MC; Doherty M; Tan H; Chan WC; Zhao H; Hallet J; Darling G; Kidane B; Wright FC; Mahar A; Davis LE; Delibasic V; Parmar A; Mittmann N; Coburn NG; Louie AV
    Oncologist; 2021 Oct; 26(10):e1800-e1811. PubMed ID: 34216415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Reported Symptoms for Esophageal Cancer Patients Undergoing Curative Intent Treatment.
    Gupta V; Allen-Ayodabo C; Davis L; Zhao H; Hallet J; Mahar AL; Ringash J; Kidane B; Darling G; Coburn NG
    Ann Thorac Surg; 2020 Feb; 109(2):367-374. PubMed ID: 31550465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does routine symptom screening with ESAS decrease ED visits in breast cancer patients undergoing adjuvant chemotherapy?
    Barbera L; Sutradhar R; Howell D; Sussman J; Seow H; Dudgeon D; Atzema C; Earle C; Husain A; Liu Y; Krzyzanowska MK
    Support Care Cancer; 2015 Oct; 23(10):3025-32. PubMed ID: 25711657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom correlates of dyspnea in advanced cancer patients using the Edmonton Symptom Assessment System.
    McKenzie E; Zhang L; Chan S; Zaki P; Razvi Y; Tsao M; Barnes E; Drost L; Yee C; Hwang M; DeAngelis C; Chow E
    Support Care Cancer; 2020 Jan; 28(1):87-98. PubMed ID: 30982093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer.
    Nagpal C; Sharma A; Bakhshi S; Malik PS; Gupta H; Mittal C; Gund S; Kumar A; Sharma A; Pushpam D; Khurana S; Pramanik R; Gupta N; Batra A
    JCO Glob Oncol; 2024 Feb; 10():e2300447. PubMed ID: 38386957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care.
    Lee G; Kim HS; Lee SW; Park YR; Kim EH; Lee B; Hu YJ; Kim KA; Kim D; Cho HY; Kang B; Choi HJ
    Eur J Cancer Care (Engl); 2020 Nov; 29(6):e13305. PubMed ID: 33016473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cancer patient-reported symptom and health utility tool for routine clinical implementation: a real-world comparison of the ESAS and EQ-5D in multiple cancer sites.
    Moskovitz M; Jao K; Su J; Brown MC; Naik H; Eng L; Wang T; Kuo J; Leung Y; Xu W; Mittmann N; Moody L; Barbera L; Devins G; Li M; Howell D; Liu G
    Curr Oncol; 2019 Dec; 26(6):e733-e741. PubMed ID: 31896943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.